Verrica Pharmaceuticals Announces Extension of FDA Review Period of its NDA for VP-102 for the Treatment of Molluscum Contagiosum
Verrica Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has extended the review ...
Read more